Van Voorhees AS, Stein Gold L, Lebwohl M, Strober B, et al. Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: results up to 32 weeks from a randomised, phase 3 study. Br J Dermatol 2021 Mar 24. doi: 10.1111/bjd.20083.
PMID: 33763874